46.46.Z - Wholesale trade of pharmaceutical and medical products
10.41 - Production of oils and other liquid fats
20.42 - Manufacture of cosmetics and toilet preparations
21.10 - Manufacture of basic pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
72.11 - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | 0,7 | 4,2 | 6,4 | 52 |
EBITDA | 0,7 | 4,5 | 6,7 | 50,3 |
Short time liabilities | 1,9 | 9,3 | 7,5 | -19,4 |
Other operating costs | ||||
Equity capital | 1,3 | 4,6 | 9,4 | 105,2 |
Operating profit (EBIT) | 0,7 | 4,3 | 6,6 | 51,3 |
Assets | 3,2 | 14,7 | 18,8 | 27,6 |
Net profit (loss) | 0,5 | 3,3 | 4,8 | 47,6 |
Cash | 0,3 | 0,3 | 3,3 | 875,9 |
Net income from sale | 14,5 | 34,1 | 64,2 | 88,5 |
Liabilities and provisions for liabilities | 1,9 | 10,1 | 9,4 | -7,4 |
Working assets | 3,1 | 12,6 | 14,2 | 12,5 |
Other income costs | ||||
Depreciation | 0 | 0,1 | 0,2 | 20,2 |
% | % | % | p.p. | |
Profitability of capital | 38,8 | 71,3 | 51,3 | -20 |
Equity capital to total assets | 41,4 | 31,1 | 50 | 18,9 |
Gross profit margin | 4,5 | 12,3 | 9,9 | -2,4 |
EBITDA Margin | 4,8 | 13,2 | 10,5 | -2,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 47 | 99 | 42 | -57 |
Current financial liquidity indicator |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane